Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital.
Quentin PerrierMélanie MinovesSophie CeranaFabienne ReymondCamille DuckiThomas DecaensAudrey LehmannPierrick BedouchPublished in: European journal of hospital pharmacy : science and practice (2023)
With ever-changing prices and new innovative treatments, such cost avoidance must be regularly evaluated. We provided objective evidence that clinical trials could achieve potential cost savings for the FHI and hospitals, in addition to the potential benefit to patients of having access to innovative investigational medicinal products.